Dr. Lappalainen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3900 Woodland Ave
Va/Mirecc
Philadelphia, PA 19104- Is this information wrong?
Education & Training
- University of Pennsylvania Health SystemFellowship, Addiction Psychiatry, 2014 - 2015
- Yale-New Haven Medical CenterResidency, Psychiatry, 2001
- OtherClass of 1992
Certifications & Licensure
- DE State Medical License 2015 - 2025
- PA State Medical License 2013 - 2024
- CT State Medical License 1999 - 2015
- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Addiction Psychiatry
Clinical Trials
- A Clinical Trial of Oral Ganaxolone in Women With Postpartum Depression Start of enrollment: 2017 Dec 28
Publications & Presentations
PubMed
- Effect of fasedienol (PH94B) pherine nasal spray and steroidal hormones on electrogram responses and autonomic nervous system activity in healthy adult volunteers.Monti, L., Hanover, R., Salmán, E., Baker, R., Smith, M., Lappalainen, J.> ;Human Psychopharmacology. 2024 Mar 1
- 18 citationsGABAA receptor occupancy by subtype selective GABAAα2,3 modulators: PET studies in humansAurelija Jucaite, Zsolt Cselényi, Jaakko Lappalainen, Dennis J. McCarthy, Chi-Ming Lee, Svante Nyberg, Katarina Varnäs, Per Stenkrona, Christer Halldin, Alan J. Cross,...> ;Psychopharmacology. 2017 Feb 1
- 36 citationsAlcohol and mortality after moderate to severe traumatic brain injury: a meta-analysis of observational studiesRahul Raj, Era D. Mikkonen, Jari Siironen, Juha Hernesniemi, Jaakko Lappalainen, Markus B. Skrifvars> ;Journal of Neurosurgery. 2016 Jun 1
- Join now to see all
Press Mentions
- Why This Seizure Drug Matters so Much for Marinus PharmaJanuary 23rd, 2017
- Marinus Announces Positive Preliminary Data from Children with CDKL5 Genetic DisorderJanuary 23rd, 2017
- Vistagen to Present Positive Fasedienol Phase 3 Data and Positive PH80 Phase 2A Data at Upcoming Scientific ConferencesNovember 8th, 2023
Hospital Affiliations
- Crozer-Chester Medical CenterChester, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: